# Trail Evaluating Particle Therapy With or Without Apatinib for H&N Adenoid Cystic Carcinoma

> **NCT02942693** · PHASE2 · UNKNOWN · sponsor: **Shanghai Proton and Heavy Ion Center** · enrollment: 50 (estimated)

## Conditions studied

- Adenoid Cystic Carcinoma

## Interventions

- **DRUG:** Apatinib
- **RADIATION:** Particle Therapy

## Key facts

- **NCT ID:** NCT02942693
- **Lead sponsor:** Shanghai Proton and Heavy Ion Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-11
- **Primary completion:** 2019-08
- **Final completion:** 2019-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2018-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02942693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02942693, "Trail Evaluating Particle Therapy With or Without Apatinib for H&N Adenoid Cystic Carcinoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02942693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*